Figure 2 (IMAGE) Impact Journals LLC Caption Figure 2: Abemaciclib shows greater potency than palbociclib & ribociclib in breast cancer cells. Credit Torres-Guzmán et. al. Usage Restrictions Original image License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.